Marketing Authorisation Holder
BEIJING INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
FOREIGN
3
Total Medicines
1
Active
3
Dosage Forms
1
Country
Kenya
(3)
Registration Status
Unknown
1
Registered
1
Withdrawn
1
Dosage Forms
TYPE 1_>700 DU/ML, TYPE 2_>500 DU/ML, TYPE 3_>700DU/ML
1
ACCEPTANCE RANGE FOR ANTIGEN CONTENT: 3.9-10.4U/DOSE (TARGET ANTIGEN CONTENT: 6.5U/DOSE)
1
(1) 0.5ML/SYRINGE (EACH PRE-FILLED SYRINGE CONTAINS 0.5ML OF PRODUCT FOR EACH ADMINISTRATION, EACH DOSE CONTAINS 6.5 U OF INACTIVATED SARSCOV-2 ANTIGEN). (2) 0.5ML/VIAL (EACH VIAL CONTAINS 0.5ML OF PRODUCT FOR EACH ADMINISTRATION, EACH DOSE CONTAINS 6.5 U OF INACTIVATED SARS-COV-2 ANTIGEN).
1
Therapeutic Classes
NEW/INNOVATOR
2
GENERIC/BIOSIMILARS
1
Local Agents / Applicants
BEIJING INSTITUTE OF...
3
Registered Medicines
Showing 3 of 3